The patients with T1-4, N0-3, Msite0-1 and adeno- or squamous carcinoma of stage IV NSCLC had a longer OS with local thoracic surgery in combination with chemotherapy or chemoradiation. Introduction Surgery plays an important role in the treatment of non–small-cell lung cancer (NSCLC) in...
Non-Small Cell Lung Cancer Stage IV Long-Term Survival With Isolated Spleen Metastasis. Ann Thorac Surg.2013 Apr; 95:1432-4.Sardenberg RA, Pinto C, Bueno CA and Younes RN: Non-small cell lung cancer stage IV long-term survival with isolated spleen metastasis. Ann Thorac Surg 95: ...
The characteristics of the patients are: 3 female, 9 male; 60 (49-73) yrs.; performance status 90; 5× squamous cell carcinoma, 7× adenocarcinoma. The response were: partial remission n = 6, no change n = 3, progressive disease n = 3. A transient neutropenia (WHO-grade ...
Patients with a history of other malignancies within 5 years, except for basal or squamous cell carcinoma of the skin, were excluded. CTC analysis 7.5 mL of blood was collected in a preservative tube (Cell-Free DNA BCT, Streck; Omaha, NE) prior to administration of chemotherapy. CTCs were ...
December 17, 2021 Association of Stage Shift and Population Mortality Among Patients With Non–Small Cell Lung Cancer Raja Flores, MD1; Parth Patel, BA1; Naomi Alpert, MS2; et al Bruce Pyenson, FSA, MAAA3,4; Emanuela Taioli, MD, PhD2 Author Affiliations Article Information JAMA Netw Open....
Immune-Related Adverse Events Supplement 4. Data Sharing Statement 1. Borghaei H, Paz-Ares L, Horn L, et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med. 2015;373(17):1627-1639. doi:10.1056/NEJMoa1507643 PubMedGoogle...
4) small cell lung cancer/limited stage 小细胞肺癌/局限期5) Non-small cell lung Carcinoma/radiotherapy 非小细胞肺癌/放射疗法6) Small-cell lung cancer/ radiotherapy 小细胞肺癌/放射疗法补充资料:肺癌经皮肿瘤内射频治疗 肺癌经皮肿瘤内射频治疗 介入放射学技术。 在经皮穿刺活检技术上发展起来的一种...
Immunotherapy targeting PD-1/PD-L1 has revolutionized the treatment of extensive-stage small cell lung cancer (ES-SCLC). However, clinical trials suggest differential efficacy of anti-PD-1 agents and anti-PD-L1 agents in first-line treatment of ES-SCLC.
Lymphocyte CD44 expression significantly increased in squamous cell carcinoma patients (P < .05) and displayed an upward trend in individuals with a history of alcohol consumption (Fig. E3E, F). Download: Download high-res image (1MB) Download: Download full-size image Fig. 3. Validation of ...
Bronchogenic carcinomaStage IASurgeryLymph node excisionMortalityTO determine the causes of death in patients treated surgically for nonsmall cell lung cancer (NSCLC) in stage IA and to evaluate the impact on survival of not performing systematic lymph node dissection and of the number of nodes ...